Verifying…
Home / Drug A–Z / Obet Benzylpenicillin Sodium Injection

Obet Benzylpenicillin Sodium Injection

NAFDAC Reg. No. C4-1230 · Drug

Registered with NAFDAC. Registration activeAs of 27 October 2026 · synced automatically from official sources.
Product
Obet Benzylpenicillin Sodium Injection
NAFDAC number
C4-1230
Active ingredient
Benzylpenicillin sodium
Strength
1 MU
Form
Powder for injection
Manufacturer
Not listed
Applicant (holder)
O-Bet Prime Drugs Pharm. Co. Ltd
Approved
10 Nov 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
9 Nov 2025
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Obet Benzylpenicillin Sodium Injection is on the NAFDAC register with an active registration (C4-1230). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What Obet Benzylpenicillin Sodium Injection is used for

From the official U.S. FDA label for benzylpenicillin sodium, the active ingredient registered with NAFDAC.

What it is used for

Therapy Penicillin G Potassium Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. Therapy with Penicillin G Potassium Injection, USP may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below; however, once these results become available, appropriate therapy should be continued. …

Possible side effects

Body as a whole: The Jarisch-Herxheimer reaction is a systemic reaction, that may occur after the initiation of penicillin therapy in patients with syphilis or other spirochetal infections ( i.e. , Lyme disease and Relapsing fever). The reaction begins one to two hours after initiation of therapy and disappears within 12 to 24 hours. It is characterized by fever, chills, myalgias, headache, exacerbation of cutaneous lesions, tachycardia, hyperventilation, vasodilation with flushing and mild hypotension. The pathogenesis of the Herxheimer reaction may be due to the release from the spirochetes of heat-stable pyrogen. …

Do not use if

A history of a hypersensitivity (anaphylactic) reaction to any penicillin is a contraindication. Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

Warnings

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens. There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe reactions when treated with cephalosporins. Before initiating therapy with penicillin G, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. …

Pregnancy & breastfeeding

Pregnancy Reproduction studies performed in the mouse, rat and rabbit have revealed no evidence of impaired fertility or harm to the fetus due to penicillin G. Human experience with the penicillins during pregnancy has not shown any positive evidence of adverse effects on the fetus. There are, however, no adequate and well controlled studies in pregnant women showing conclusively that harmful effects of these drugs on the fetus can be excluded. …

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Obet Benzylpenicillin Sodium Injection

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Obet Benzylpenicillin Sodium Injection

What is in Obet Benzylpenicillin Sodium Injection?

Obet Benzylpenicillin Sodium Injection contains Benzylpenicillin sodium (1 MU), as powder for injection, according to its NAFDAC registration record.

Is Obet Benzylpenicillin Sodium Injection registered with NAFDAC?

Yes. Obet Benzylpenicillin Sodium Injection is listed on the NAFDAC register under registration number C4-1230, and its registration is active as of 27 October 2026.

Has Obet Benzylpenicillin Sodium Injection been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Obet Benzylpenicillin Sodium Injection in our automatically synced alert list.

How can I check that my pack of Obet Benzylpenicillin Sodium Injection is genuine?

Run a free authenticity scan with the NAFDAC number C4-1230, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Obet Benzylpenicillin Sodium Injection used for?

Therapy Penicillin G Potassium Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. Therapy with P (Summarised from the official U.S. FDA label for benzylpenicillin sodium. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Obet Benzylpenicillin Sodium Injection? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.